Novel Peptides Targeting Metabolic Disease

Novel Peptides Targeting Metabolic Disease
Navigation
  • Home
  • About
  • Drug Discovery
  • Peptides
    • Custom Synthesis
    • Peptide Catalog
  • News
  • Contact
  • Home
  • About
  • Drug Discovery
  • Peptides
    • Custom Synthesis
    • Peptide Catalog
  • News
  • Contact
View Post

AmideBio Awarded SBIR Phase IIB Grant to Support Pre-Clinical Development of its Long- Acting Stable Glucagon Analog for the Treatment of Hyperinsulinism

In News by Alan StenbackOctober 4, 2022

BOULDER, CO, October 4th, 2022 – AmideBio, LLC, a privately held biopharmaceutical company, announced today that it has received $2.69M in funding through a Phase IIB Small Business Innovation Research …

Professional Website Services by Stenback Digital Media

  • Home
  • About
  • Drug Discovery
  • Peptides
  • News
  • Contact
  • Privacy Policy
  • FCOI Policy